These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4378429)

  • 21. The formation and release of slow-reacting substance of anaphylaxis.
    Orange RP
    Monogr Allergy; 1977; 12():231-40. PubMed ID: 335216
    [No Abstract]   [Full Text] [Related]  

  • 22. Computerization of a bioassay: quantitation of slow reacting substance of anaphylaxis (SRS-A).
    Fleisch JH; Zaborowsky BR; Cerimele BJ; Spaethe SM
    J Pharmacol Exp Ther; 1979 May; 209(2):238-43. PubMed ID: 86610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symposium on allergic lung disease. IV. Immunologic mechanisms for release of chemical mediators of anaphylaxis from human lung tissue.
    Kaliner M
    Can Med Assoc J; 1974 Feb; 110(4):431 passim. PubMed ID: 4134081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Slow reacting substance of anaphylaxis (SRS-A) release from guinea-pig lung parenchyma during antigen- or ionophore-induced contraction.
    Fleisch JH; Haisch KD; Spaethe SM
    J Pharmacol Exp Ther; 1982 Apr; 221(1):146-51. PubMed ID: 6801255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The release of four mediators of immediate hypersensitivity from human leukemic basophils.
    Lewis RA; Goetzl EJ; Wasserman SI; Valone FH; Rubin RH; Austen KF
    J Immunol; 1975 Jan; 114(1 Pt 1):87-92. PubMed ID: 46247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-immunological release of slow-reacting substance from guinea-pig lungs.
    Piper PJ; Seale JP
    Br J Pharmacol; 1979 Sep; 67(1):67-72. PubMed ID: 91403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slow reacting substance of anaphylaxis (SRS-A): cellular controls of synthesis and biological effects of its constituent leukotrienes.
    Lewis RA; Austen KF
    Prog Lipid Res; 1981; 20():713-8. PubMed ID: 7342125
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of slow reacting substance of anaphylaxis (SRS-A) in plasma of guinea pigs during anaphylaxis.
    Stechschulte DJ; Orange RP; Austen KF
    J Immunol; 1973 Nov; 111(5):1585-9. PubMed ID: 4126780
    [No Abstract]   [Full Text] [Related]  

  • 29. Modulation of the immunological release of the eosinophil chemotactic factor of anaphylaxis from human lung.
    Wasserman SI; Goetzl EJ; Kaliner M; Austen KF
    Immunology; 1974 Apr; 26(4):677-84. PubMed ID: 4137063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rat passive peritoneal anaphylaxis following sensitisation with guinea pig antiserum: an immediate hypersensitivity reaction without histamine release.
    Smith H; Ross JW; Spicer BA
    Int Arch Allergy Appl Immunol; 1980; 62(2):195-204. PubMed ID: 6154654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotaxis of eosinophil leukocytes in relation to immediate-type hypersensitivity and the complement system.
    Kay AB
    Antibiot Chemother (1971); 1974; 19():271-83. PubMed ID: 4142850
    [No Abstract]   [Full Text] [Related]  

  • 32. The capacity of human immunoglobulin E to mediate the release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung.
    Ishizaka T; Ishizaka K; Orange RP; Austen KF
    J Immunol; 1970 Feb; 104(2):335-43. PubMed ID: 4189671
    [No Abstract]   [Full Text] [Related]  

  • 33. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociation of the immunologic release of histamine and slow reacting substance of anaphylaxis from human lung using cytochalasins A and B-1.
    Orange RP
    J Immunol; 1975 Jan; 114(1 Pt 1):182-6. PubMed ID: 46240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat.
    Stechschulte DJ; Austen KF; Bloch KJ
    J Exp Med; 1967 Jan; 125(1):127-47. PubMed ID: 4163357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Slow reacting substance as a preformed mediator from human lung.
    Turnbull LS; Jones DG; Kay AB
    Immunology; 1976 Nov; 31(5):813-20. PubMed ID: 11180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin.
    Hope WC; Welton AF; Fiedler-Nagy C; Batula-Bernardo C; Coffey JW
    Biochem Pharmacol; 1983 Jan; 32(2):367-71. PubMed ID: 6191762
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inhibition of the slow-reacting substance of anaphylaxis generation by ubiquinone derivatives].
    Ashida Y; Okamoto K; Maki Y
    Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):189-94. PubMed ID: 3792955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative studies on immunologically and non-immunologically produced slow-reacting substances from man, guinea-pig and rat.
    Morris HR; Piper PJ; Taylor GW; Tippins JR
    Br J Pharmacol; 1979 Oct; 67(2):179-84. PubMed ID: 40646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the formation and release of bovine SRS-A in vitro by several anti-anaphylactic drugs.
    Burka JF; Eyre P
    Int Arch Allergy Appl Immunol; 1975; 49(6):774-81. PubMed ID: 811569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.